These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20018467)

  • 1. Hormone replacement after gynaecological cancer.
    Singh P; Oehler MK
    Maturitas; 2010 Mar; 65(3):190-7. PubMed ID: 20018467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopause, hormone replacement and gynaecological cancers.
    Hinds L; Price J
    Menopause Int; 2010 Jun; 16(2):89-93. PubMed ID: 20729501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of hormone replacement therapy in gynaecological cancer survivors.
    Biliatis I; Thomakos N; Rodolakis A; Akrivos N; Zacharakis D; Antsaklis A
    J Obstet Gynaecol; 2012 May; 32(4):321-5. PubMed ID: 22519472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy after treatment for a gynaecological malignancy.
    O'Donnell RL; Clement KM; Edmondson RJ
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):32-41. PubMed ID: 26626038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal replacement therapy after gynaecological cancer.
    Biglia N; Mariani L; Marenco D; Robba C; Peano E; Kubatzki F; Sismondi P
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):191-6. PubMed ID: 17068403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing menopausal symptoms after gynecological cancer.
    Michaelson-Cohen R; Beller U
    Curr Opin Oncol; 2009 Sep; 21(5):407-11. PubMed ID: 19587594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynaecological oncology perspective on management of the menopause.
    Rees M
    Eur J Surg Oncol; 2006 Oct; 32(8):892-7. PubMed ID: 16698224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and women with premature menopause--a cancer survivorship issue.
    King J; Wynne CH; Assersohn L; Jones A
    Eur J Cancer; 2011 Jul; 47(11):1623-32. PubMed ID: 21561765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy in gynecologic cancer survivors: why not?
    Ibeanu O; Modesitt SC; Ducie J; von Gruenigen V; Agueh M; Fader AN
    Gynecol Oncol; 2011 Aug; 122(2):447-54. PubMed ID: 21474167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
    J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function.
    Huang KE; Xu L; I NN; Jaisamrarn U
    Maturitas; 2010 Mar; 65(3):276-83. PubMed ID: 20018469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen therapy in gynecological cancer survivors.
    Guidozzi F
    Climacteric; 2013 Dec; 16(6):611-7. PubMed ID: 23952524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and management of the hormone replacement therapy (HRT) candidate.
    Hillard T
    Int J Fertil Womens Med; 1997; 42 Suppl 2():347-64. PubMed ID: 9397383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O; Metsä-Heikkilä M
    Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.